Valuation: Adocia

Market Cap 78.62M 90.51M 73M 67.33M 127M 8.64B 129M 864M 338M 4.29B 340M 332M 14.43B P/E 2026 *
-733x
P/E 2027 * 5.81x
Enterprise Value 48.77M 56.15M 45.29M 41.77M 78.68M 5.36B 80.1M 536M 210M 2.66B 211M 206M 8.95B EV / Sales 2026 *
19.3x
EV / Sales 2027 * 3.07x
Free-Float
95.03%
Yield 2026 *
-
Yield 2027 * -
1 day-0.50%
1 week+5.43%
Current month-3.43%
1 month-1.58%
3 months-15.97%
6 months-33.59%
Current year-40.33%
1 week 3.69
Extreme 3.694
4.06
1 month 3.61
Extreme 3.61
4.53
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 80 2012-02-23
Director/Board Member 58 2013-06-17
Date Insider Type Main position Quantity % Market Cap.
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+5.43%-48.28%-23.41% 89.47M
-3.74%-1.56%+45.14%+64.45% 55.2B
-0.81%-0.33%+27.15%+81.12% 55.6B
-0.11%+0.86%-15.63%-14.71% 23.51B
-1.58%-5.51%-3.51%+359.44% 22.35B
-4.01%-2.68%+12.50%-12.70% 20.6B
-1.23%-3.51%+25.70%-31.88% 17.45B
-3.34%-6.96%+22.02%+515.48% 15.16B
+1.16%+0.58%+51.87%+183.97% 13.91B
-5.09%-13.14%+151.85%+272.20% 13.74B
Average -1.92%-0.80%+26.88%+139.40% 23.76B
Weighted average by Cap. -2.10%-0.46%+31.14%+122.26%

Financials

2026 *2027 *
Net sales 2.52M 2.9M 2.34M 2.16M 4.07M 277M 4.14M 27.72M 10.85M 138M 10.9M 10.66M 463M 35.4M 40.76M 32.87M 30.32M 57.11M 3.89B 58.14M 389M 152M 1.93B 153M 150M 6.5B
Net income -4.32M -4.97M -4.01M -3.7M -6.96M -474M -7.09M -47.46M -18.58M -236M -18.66M -18.26M -793M -44.33M -51.03M -41.16M -37.96M -71.51M -4.87B -72.8M -487M -191M -2.42B -192M -187M -8.14B
Net Debt -29.84M -34.36M -27.71M -25.56M -48.14M -3.28B -49.02M -328M -128M -1.63B -129M -126M -5.48B 30.18M 34.74M 28.02M 25.84M 48.68M 3.32B 49.56M 332M 130M 1.65B 130M 128M 5.54B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26-07-30 3.998 -0.50% 55,437
26-07-29 €4.018 +1.46% 73,512
26-07-28 €3.960 +1.54% 49,930
26-07-27 €3.900 +1.56% 108,008
26-07-24 €3.840 +0.52% 65,097
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.018EUR
Average target price
9.700EUR
Spread / Average Target
+141.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock